Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1958 4
1959 3
1960 4
1962 2
1963 1
1964 1
1965 1
1972 5
1973 9
1974 6
1975 2
1976 5
1977 14
1978 5
1980 2
1982 1
1983 3
1984 3
1985 8
1986 11
1987 12
1988 20
1989 16
1990 10
1991 12
1992 12
1993 10
1994 13
1995 13
1996 5
1997 12
1998 3
1999 7
2000 7
2001 7
2002 6
2003 6
2004 5
2005 3
2006 9
2007 5
2008 1
2009 4
2010 1
2011 2
2013 1
2014 2
2015 5
2016 2
2017 3
2018 5
2019 1
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Levobunolol.
[No authors listed] [No authors listed] 2021 Sep 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Sep 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000211 Free Books & Documents. Review.
Based on its physicochemical properties and its ophthalmic route of administration, levobunolol appears to present a moderately low risk to the breastfed infant. ...
Based on its physicochemical properties and its ophthalmic route of administration, levobunolol appears to present a moderately low r …
Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis.
Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K. Li T, et al. Ophthalmology. 2016 Jan;123(1):129-40. doi: 10.1016/j.ophtha.2015.09.005. Epub 2015 Oct 31. Ophthalmology. 2016. PMID: 26526633 Free PMC article. Review.
The mean reductions (95% credible intervals) in IOP in millimeters of mercury at 3 months ordered from the most to least effective drugs were as follows: bimatoprost 5.61 (4.94; 6.29), latanoprost 4.85 (4.24; 5.46), travoprost 4.83 (4.12; 5.54), levobunolol 4.51 (3.85; 5.2 …
The mean reductions (95% credible intervals) in IOP in millimeters of mercury at 3 months ordered from the most to least effective drugs wer …
Superior oblique myokymia.
Zhang M, Gilbert A, Hunter DG. Zhang M, et al. Surv Ophthalmol. 2018 Jul-Aug;63(4):507-517. doi: 10.1016/j.survophthal.2017.10.005. Epub 2017 Oct 19. Surv Ophthalmol. 2018. PMID: 29056504 Review.
Recently, topical beta blockers have managed SOM symptoms in a number of cases, including the first case treated with levobunolol. Systemic medications, strabismus surgery, and neurosurgery have been used to control symptoms, with strabismus surgery carrying a moderate ris …
Recently, topical beta blockers have managed SOM symptoms in a number of cases, including the first case treated with levobunolol. Sy …
Drugs for common eye disorders.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Dec 2;61(1586):187-194. Med Lett Drugs Ther. 2019. PMID: 31770361 Review. No abstract available.
Levobunolol-imprinted polymer: a theoretical study.
Maia PP, Guimarães L, Nascimento CS Jr. Maia PP, et al. J Mol Model. 2023 Oct 20;29(11):346. doi: 10.1007/s00894-023-05757-4. J Mol Model. 2023. PMID: 37861808
CONTEXT: Levobunolol is a beta-blocker drug prescribed for the control and prevention of cardiovascular events, such as individuals with cardiac arrhythmia or a history of myocardial infarction. Creating a levobunolol-specific molecularly imprinted polymer (MIP) all …
CONTEXT: Levobunolol is a beta-blocker drug prescribed for the control and prevention of cardiovascular events, such as individuals w …
[Vistagan-Liquifilm in the treatment of simple glaucoma].
Szymankiewiczowa S. Szymankiewiczowa S. Klin Oczna. 1989 Jun;91(6):163-4. Klin Oczna. 1989. PMID: 2576678 Clinical Trial. Polish.
In the period of 3 months they were given twice daily a 0.5% solution of Vistagan-Liquifilm, a compound blocking as well the beta 1 as the beta 2 receptors. ...
In the period of 3 months they were given twice daily a 0.5% solution of Vistagan-Liquifilm, a compound blocking as well the beta 1 a …
Treatment of glaucoma.
Remis LL, Epstein DL. Remis LL, et al. Annu Rev Med. 1984;35:195-205. doi: 10.1146/annurev.me.35.020184.001211. Annu Rev Med. 1984. PMID: 6426371 Review.
Transdermal delivery of beta-blockers.
Aqil M, Sultana Y, Ali A. Aqil M, et al. Expert Opin Drug Deliv. 2006 May;3(3):405-18. doi: 10.1517/17425247.3.3.405. Expert Opin Drug Deliv. 2006. PMID: 16640500 Review.
Nevertheless, there have been noteworthy research endeavours worldwide at the laboratory level to investigate the skin permeation and to develop transdermal formulations of beta-blockers including: propranolol, metoprolol, atenolol, timolol, levobunolol, bupranolol, bopind …
Nevertheless, there have been noteworthy research endeavours worldwide at the laboratory level to investigate the skin permeation and to dev …
A multicenter evaluation of levobunolol (Vistagan) in Germany.
Novack GD, Kelley EP, Lue JC. Novack GD, et al. Ophthalmologica. 1988;197(2):90-6. doi: 10.1159/000309926. Ophthalmologica. 1988. PMID: 3054684 Clinical Trial.
We evaluated the efficacy and safety of 0.5% levobunolol HC1 (Vistagan) in 2,041 glaucoma patients at 143 sites in the Federal Republic of Germany. This study was a 3-month, open-label, noncomparative trial of levobunolol administered twice daily. Eighty-five …
We evaluated the efficacy and safety of 0.5% levobunolol HC1 (Vistagan) in 2,041 glaucoma patients at 143 sites in the Federal …
Two new drugs for glaucoma.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Jul 16;60(1551):117-120. Med Lett Drugs Ther. 2018. PMID: 30036347 No abstract available.
314 results